C006 - Derm Exam Prep Course: Refresher

Friday, February 16; 9:00 AM - 4:00 PM

Learning Objectives

Following this course, the attendee should be able to:

• Diagnose general dermatologic conditions and diseases within the American Board of Dermatology standards for competency
• Identify areas needing additional study in preparation for the General Dermatology module of the MOC Recertification examination
• Self-assess current knowledge and reflection on clinical practice as stimulated by the dermatologic images, anonymous benchmarking feedback and discussion at the course

Description

This course is targeted to dermatologists preparing for the American Board of Dermatology (ABD) Maintenance of Certification (MOC)/Recertification Examination. The course will review the 150 specific disease states provided by the ABD as a study guide for the General Dermatology module of the MOC exam in a format similar to the one used on the exam. The course will provide the audience with an opportunity to identify dermatologic diseases based on images. Note: This course reviews only diagnoses for the General Dermatology module and does NOT include questions from the Subspecialty modules. This activity has been approved by the American Board of Dermatology (ABD) for up to 141 MOC Component 2 Self-Assessment points. For more information about MOC, please visit the ABD website at www.abderm.org.

Disclosures

• Burkemper, Nicole M., MD: no financial relationships exist with commercial interests.
• Carr, David R., MD: no financial relationships exist with commercial interests.
• Diaz, Lucia Zoraida, MD: no financial relationships exist with commercial interests.
• Halverstam, Caroline P., MD: no financial relationships exist with commercial interests.
• Hurley, M. Yadira, MD: Actelion – C(H), I(Grants/Research Funding), SP(H); Centocor Ortho Biotech Inc. – I(Grants/Research Funding); Genentech, Inc. – I(Grants/Research Funding); InflaRx GmbH – I(Grants/Research Funding); Novartis – I(Grants/Research Funding); Pfizer Inc. – I(Grants/Research Funding); Regeneron – I(Grants/Research Funding); Seattle Genetics – C(H);
• Johnson, Luke Samuel, MD: no financial relationships exist with commercial interests.
• Kim, Soo Jung, MD, PhD: no financial relationships exist with commercial interests.
• Maher, Ian A., MD: Castle Biosciences – I(Grants/Research Funding); Regeneron Pharmaceuticals, Inc. – I(Grants/Research Funding); Roche Laboratories – I(Grants/Research Funding);
• Mann, Margaret W., MD: Galderma USA – I(Grants/Research Funding); Merz Aesthetics – I(Fees); Sciton Inc. – I(EQ);
• Mesinkovska, Natasha Atanaskova, MD, PhD: BiologicsMD, Inc. – C(H);
• Newman, Catherine Clayton, MD: no financial relationships exist with commercial interests.
• Tarbox, Michelle B., MD: no financial relationships exist with commercial interests.
• Tom, Wynnis L., MD: Celgene Corporation – I(NC); Demira – I(NC); Janssen Pharmaceuticals, Inc – I(NC); Medimetriks Pharmaceuticals, Inc. – I(NC); Otsuka Pharmaceutical Co., Ltd. – I(NC); Pfizer Inc. – I(NC); Regeneron – I(NC); Symbio – I(NC);
• West, Daniel A, MD: no financial relationships exist with commercial interests.